LLY

755.74

-0.21%↓

JNJ

152.57

+0.85%↑

UNH

315.59

+8.36%↑

ABBV

185.7

+0.95%↑

NVO

66.94

+4.04%↑

LLY

755.74

-0.21%↓

JNJ

152.57

+0.85%↑

UNH

315.59

+8.36%↑

ABBV

185.7

+0.95%↑

NVO

66.94

+4.04%↑

LLY

755.74

-0.21%↓

JNJ

152.57

+0.85%↑

UNH

315.59

+8.36%↑

ABBV

185.7

+0.95%↑

NVO

66.94

+4.04%↑

LLY

755.74

-0.21%↓

JNJ

152.57

+0.85%↑

UNH

315.59

+8.36%↑

ABBV

185.7

+0.95%↑

NVO

66.94

+4.04%↑

LLY

755.74

-0.21%↓

JNJ

152.57

+0.85%↑

UNH

315.59

+8.36%↑

ABBV

185.7

+0.95%↑

NVO

66.94

+4.04%↑

Kodu・Aktsiate loetelu・CorMedix Inc

CorMedix Inc

Suletud

SektorTervishoid

12.73 3.83

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

12.1

Max

12.77

Põhinäitajad
By Trading Economics
Sissetulek	7.2M 21M
Müük	7.9M 39M
P/E Sektori keskmine	47.44 56.602
Aktsiakasum	0.299
Kasumimarginaal	52.822
Töötajad	64
EBITDA	16M 14M

Soovitused
By TipRanks
Soovitused	Tugev "osta" hinnang
12 kuu keskmine prognoos	+43.89% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	13. aug 2025

Turustatistika
By TradingEconomics
Turukapital	168M 804M
Eelmine avamishind	8.9
Eelmine sulgemishind	12.73

Uudiste sentiment

By Acuity

50%

198 / 382 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Strong Bullish Evidence

9.2 / N/A Toetus ja vastupanu

CorMedix Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

19. mai 2025, 20:40 UTC

Omandamised, ülevõtmised, äriostud

FedEx Names CEO, Chairman for Planned Freight Spinoff

20. mai 2025, 00:00 UTC

Peamised uudised

America's Fiscal Situation Threatens the Good Mood on Wall Street -- WSJ

19. mai 2025, 23:48 UTC

Market Talk

Nikkei May Rise as Fears About Moody's U.S. Downgrade Ease -- Market Talk

19. mai 2025, 23:43 UTC

Market Talk

Gold Edges Lower on Possible Technical Correction -- Market Talk

19. mai 2025, 22:33 UTC

Market Talk

Uranium Buyers Could Accelerate Restocking -- Market Talk

19. mai 2025, 22:16 UTC

Omandamised, ülevõtmised, äriostud

Yuexiu Property to Use Divestment Proceeds for Business Development Purposes

19. mai 2025, 22:16 UTC

Omandamised, ülevõtmised, äriostud

Yuexiu Property to Sell Stake for CNY4.15B

19. mai 2025, 22:15 UTC

Omandamised, ülevõtmised, äriostud

Yuexiu Property to Sell Stake to China Resources Land

19. mai 2025, 22:15 UTC

Omandamised, ülevõtmised, äriostud

Yuexiu Property to Sell 65% Stake in Beijing Haizhen Real Estate

19. mai 2025, 22:02 UTC

Tulu

Trip.com Group 1Q Rev $1.9B >TCOM

19. mai 2025, 22:02 UTC

Tulu

Trip.com Group 1Q Adj EPS 82c >TCOM

19. mai 2025, 22:02 UTC

Tulu

Trip.com Group 1Q EPS 84c >TCOM

19. mai 2025, 21:58 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

19. mai 2025, 21:58 UTC

Market Talk

Global Equities Roundup: Market Talk

19. mai 2025, 21:58 UTC

Market Talk

Automakers to Raise Prices by End of June, Toyota COO Says -- Market Talk

19. mai 2025, 21:50 UTC

Tulu

Home Depot's Earnings Could Mirror a Sluggish Housing Market -- Barrons.com

19. mai 2025, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

19. mai 2025, 20:21 UTC

Omandamised, ülevõtmised, äriostud

FedEx: R. Brad Martin, Vice Chmn of the FedEx Corp. Bd of Directors, Agreed to Serve as Chmn of the Bd of FedEx Freight >FDX

19. mai 2025, 20:21 UTC

Omandamised, ülevõtmised, äriostud

FedEx: Both Appointments Will Be Effective Upon Completion of the Previously Announced Separation of FedEx Freight From FedEx Corp. >FDX

19. mai 2025, 20:21 UTC

Omandamised, ülevõtmised, äriostud

FedEx: Plans for the Spinoff, Which Is Expected to Occur by June 2026, Remain on Track >FDX

19. mai 2025, 20:21 UTC

Omandamised, ülevõtmised, äriostud

FedEx: Announces Leadership for Independent FedEx Freight Co Upon Separation

19. mai 2025, 20:21 UTC

Omandamised, ülevõtmised, äriostud

FedEx: John A. Smith, Oper Chief, U.S. and Canada, of Federal Express, Has Been Selected as Pres and CEO of FedEx Freight >FDX

19. mai 2025, 20:20 UTC

Peamised uudised

Major U.S. Stock Indexes Finish Higher; Dollar Falls -- WSJ

19. mai 2025, 20:15 UTC

Omandamised, ülevõtmised, äriostud

U.S. Steel Stock Rises on Report of Better Nippon Offer. Why Trump Could Say 'Yes.' -- Barrons.com

19. mai 2025, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

19. mai 2025, 19:59 UTC

Peamised uudised

JPMorgan CEO Dimon Still Intends to Step Down in Next Few Years. 'It's Up to the Board.' -- Barrons.com

19. mai 2025, 19:58 UTC

Market Talk

Estonia Redirects Ships After Russia Detains Greek Tanker -- Market Talk

19. mai 2025, 19:52 UTC

Market Talk

Imports Accelerate at Southern California Ports -- Market Talk

19. mai 2025, 19:16 UTC

Market Talk

Oil Futures Edge Up After Shaky Start -- Market Talk

19. mai 2025, 19:00 UTC

Suurimad hinnamuutused turgudel

Omandamised, ülevõtmised, äriostud

Sanmina Shares Fall After Deal to Buy AMD's Newly Acquired Manufacturing Company

Võrdlus sarnastega

Hinnamuutus

CorMedix Inc Prognoos

Hinnasiht

By TipRanks

43.89% tõus

12 kuu keskmine prognoos

Keskmine 17.67 USD 43.89%

Kõrge 20 USD

Madal 13 USD

Põhineb 6 Wall Streeti analüütiku instrumendi CorMedix Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

6 ratings

Osta

Hoia

Müü

Põhineb 6 analüütiku instrumendi CorMedix Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

9.2 / N/AToetus ja vastupanu

Recent bullish events outweigh bearish events.

All events are bullish.

Sentiment

By Acuity

198 / 382 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest CorMedix Inc

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.